Arthritis News and Research

Latest Arthritis News and Research

Prism Pharmaceuticals to be acquired by Baxter

Prism Pharmaceuticals to be acquired by Baxter

From Baxter International Inc. 20 Apr 2011
LMP1 viral protein needs TRAF6 cellular protein to promote B cell activation signaling pathways: Study

LMP1 viral protein needs TRAF6 cellular protein to promote B cell activation signaling pathways: Study

20 Apr 2011
Rituxan receives FDA approval for treating two rare diseases

Rituxan receives FDA approval for treating two rare diseases

20 Apr 2011
FDA approves Rituxan-corticosteroid combination for Wegener's Granulomatosis and Microscopic Polyangiitis

FDA approves Rituxan-corticosteroid combination for Wegener's Granulomatosis and Microscopic Polyangiitis

20 Apr 2011
Johnson & Johnson reports net sales of $16.2 billion for first quarter 2011

Johnson & Johnson reports net sales of $16.2 billion for first quarter 2011

19 Apr 2011
Canada needs to modernize its pharmaceutical laws to ensure drug safety: CMAJ

Canada needs to modernize its pharmaceutical laws to ensure drug safety: CMAJ

19 Apr 2011
Mother's diet during pregnancy can influence child's risk of obesity

Mother's diet during pregnancy can influence child's risk of obesity

19 Apr 2011
HHWC introduces Executive Edge Wellness Program

HHWC introduces Executive Edge Wellness Program

19 Apr 2011
Tweaking gene in satellite cells may increase lifespan of people with muscular dystrophy

Tweaking gene in satellite cells may increase lifespan of people with muscular dystrophy

18 Apr 2011
FDA accepts Regeneron's VEGF Trap-Eye BLA for review

FDA accepts Regeneron's VEGF Trap-Eye BLA for review

18 Apr 2011
Scientists develop new compound for multiple sclerosis treatment

Scientists develop new compound for multiple sclerosis treatment

18 Apr 2011
Scientist discovers new molecular mechanism underlying asthma, COPD

Scientist discovers new molecular mechanism underlying asthma, COPD

18 Apr 2011
Top-line results from Pfizer's tofacitinib Phase 3 study in rheumatoid arthritis

Top-line results from Pfizer's tofacitinib Phase 3 study in rheumatoid arthritis

15 Apr 2011
JNJ, Merck sign distribution agreement for REMICADE and SIMPONI

JNJ, Merck sign distribution agreement for REMICADE and SIMPONI

15 Apr 2011
Genentech receives FDA approval for Actemra to treat juvenile idiopathic arthritis

Genentech receives FDA approval for Actemra to treat juvenile idiopathic arthritis

15 Apr 2011
Researchers report injectable gel can help treat arthritis

Researchers report injectable gel can help treat arthritis

15 Apr 2011
AHRQ finds 52% increase in medication side effects, injuries between 2004 and 2008

AHRQ finds 52% increase in medication side effects, injuries between 2004 and 2008

15 Apr 2011
Study: Simple illusion can reduce arthritic pain

Study: Simple illusion can reduce arthritic pain

15 Apr 2011
Specific oestrogen might serve as effective treatment for osteoporosis

Specific oestrogen might serve as effective treatment for osteoporosis

12 Apr 2011
Positive interim results from PROLOR's hGH-CTP Phase II trial in growth hormone deficiency

Positive interim results from PROLOR's hGH-CTP Phase II trial in growth hormone deficiency

11 Apr 2011

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback